Founded in 2006, Biosensis is a leader in supporting researchers in academia and industry worldwide. With extensive experience in life science research and decades of expertise in commercializing antibodies, reagents, and ELISA Kits for research and diagnostics, Biosensis demonstrates a deep understanding of researchers' needs for high-quality, reliable reagents. Supported by over 400 peer-reviewed publications, Biosensis has delivered scientific expertise in neuroscience and its related fields.
Biosensis specializes in ELISA Kits, antibodies, and dyes and tracing reagents tailored for neuroscience research, with a focus on neurodegenerative diseases, neurodevelopment, and neuro-metabolism. Key research areas include Alzheimer's, Parkinson's, ALS, autophagy, metabolic and stress disorders, obesity, and neuroinflammation. For nearly 30 years, Biosensis has been a global leader in neurotrophins and neurotrophin receptors.
